RULES WERE NOT MEANT FOR THIS BMW. There's a reason the 2 Series is so loved. Blisteringly fast, the 335-horsepower rear-wheel drive M240i Coupe sprints from 0 to 60 mph in just 4.4 seconds, or 4.2 seconds with xDrive, and handles with a steering agility and control that are incredibly precise.
FDA Approves Tecentriq Immunotherapy for Specific Type of Advanced Lung Cancer. The U.S. Food and Drug Administration (FDA) approved Genentechâs Tecentriq (atezolizumab) as a treatment for people with metastatic non-small cell lung cancer (NSCLC).
Five days after the approval of OPDIVO for the treatment of patients with metastatic squamous non-small cell lung cancer ( NSCLC ) with progression on or after platinum -based chemotherapy , the National Comprehensive Cancer NetworkÂ® ( NCCNÂ® ) and their expert panel have made an interim update to the NCCN GuidelinesÂ® to include nivolumab ( OPDIVO ) ...